Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vigonvita Life Sciences CoHKSE:02630 +5.32%8 Market Cap is HK$15,083.8 Mil as of Jul. 28, 2026. GuruFocus rates HKSE:02630 with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Vigonvita Life Sciences Co ranks better than 84.67% on this metric.
Vigonvita Life Sciences Co's quarterly market cap
stayed the same
from Dec. 2023 (HK$0.0 Mil) to Dec. 2024 (HK$0.0 Mil) but then
increased
from Dec. 2024 (HK$0.0 Mil) to Dec. 2025 (HK$13,743.0 Mil).
Vigonvita Life Sciences Co's annual market cap
stayed the same
from Dec. 2023 (HK$0.0 Mil) to Dec. 2024 (HK$0.0 Mil) but then
increased
from Dec. 2024 (HK$0.0 Mil) to Dec. 2025 (HK$13,743.0 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Vigonvita Life Sciences Co's Enterprise Value for Today is HK$14,459.2 Mil.
Vigonvita Life Sciences Co (HKSE:02630) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Vigonvita Life Sciences Co Market Cap Related Terms
Vigonvita Life Sciences Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vigonvita Life Sciences Co Market Cap Chart
Vigonvita Life Sciences Co Annual Data
Trend
Dec23
Dec24
Dec25
Market Cap
0.00
0.00
13,743.04
Vigonvita Life Sciences Co Semi-Annual Data
Dec23
Dec24
Dec25
Market Cap
0.00
0.00
13,743.04
HKSE:02630 vs LLY, JNJ, ABBV: Market Cap Comparison
For the Drug Manufacturers - General subindustry, Vigonvita Life Sciences Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vigonvita Life Sciences Co Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vigonvita Life Sciences Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Vigonvita Life Sciences Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vigonvita Life Sciences Co (HKSE:02630) has a Market Cap of HK$15,083.8 Mil as of Jul. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Vigonvita Life Sciences Co and its competitors. According to the industry distribution chart, Vigonvita Life Sciences Co ranks #157 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 15.3%.
Is Vigonvita Life Sciences Co's Market Cap too high?
Vigonvita Life Sciences Co's current Market Cap is HK$15,083.8 Mil. Based on the distribution chart, Vigonvita Life Sciences Co ranks #157 out of 1024 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vigonvita Life Sciences Co has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Vigonvita Life Sciences Co's Market Cap compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Vigonvita Life Sciences Co ranks #157 out of 1024 companies for Market Cap. This places Vigonvita Life Sciences Co in the top 15% of its industry — outperforming the majority of peers. The industry median Market Cap is 215.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 215.70, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Vigonvita Life Sciences Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 215.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vigonvita Life Sciences Co's current Market Cap is HK$15,083.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vigonvita Life Sciences Co stock overvalued right now?
Vigonvita Life Sciences Co (HKSE:02630) has a current Market Cap of HK$15,083.8 Mil. The current Market Cap is HK$15,083.8 Mil. Vigonvita Life Sciences Co's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Vigonvita Life Sciences Co (HKSE:02630), the current Market Cap is HK$15,083.8 Mil as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vigonvita Life Sciences Co Ltd biopharmaceutical company. It is focused on innovation driven biopharmaceutical development, with a strategic emphasis on addressing unmet clinical needs in the treatment of neuropsychiatric, infectious, and andrological diseases. The company's core Products include LV232, anti-depression drug candidate, VV913: a novel investigational drug candidate for premature ejaculation and, VV116: an oral nucleoside analog with broad-spectrum antiviral potential. The company's operations are located in the PRC and Uzbekistan. Revenue is generated from the out-licensing and the sales of its pharmaceutical products.
8GF Score
Get the complete analysis for HKSE:02630
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02630 has been successfully added to your 
